Sanofi (SAN) News Today €84.49 -0.87 (-1.02%) As of 08/29/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainabilityBuy This Stock SAN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia4 hours ago | finance.yahoo.comSanofi wins FDA nod for Wayrilz in bleeding disorder thrombocytopeniaAugust 31 at 9:11 AM | seekingalpha.comSanofi Gets Boost as FDA Clears Autoimmune Blood Disorder DrugAugust 30 at 3:39 AM | bloomberg.comScientists Say a New Vaccine Could Finally Cure AcneAugust 29 at 10:39 PM | msn.comSanofi Gets FDA Approval for Blood Disorder TreatmentAugust 29 at 10:39 PM | marketwatch.comRegeneron and Sanofi’s DUPIXENT® Study: A Closer Look at EoE TreatmentAugust 29 at 12:50 PM | tipranks.comSanofi’s Rilzabrutinib Gains EU Orphan Designation for IgG4-Related DiseaseAugust 29 at 11:11 AM | tipranks.comSanofi (SNY) Receives Orphan Designation for RilzabrutinibAugust 26, 2025 | insidermonkey.comSanofi’s SAR445877 Study: A New Hope in Cancer Treatment?August 24, 2025 | tipranks.comSanofi’s Promising CIDP Treatment Study: A Potential Game-Changer?August 24, 2025 | tipranks.comSanofi’s Dupilumab Study: A Potential Game-Changer for Chronic PruritusAugust 24, 2025 | tipranks.comRegeneron and Sanofi’s Dupilumab Study: A Potential Game Changer for Pediatric Prurigo NodularisAugust 24, 2025 | tipranks.comSanofi’s New Vaccine Study: A Potential Game-Changer in Infant ImmunizationAugust 24, 2025 | tipranks.comSanofi’s New Vaccine Study: A Potential Game-Changer for Infant ImmunizationAugust 24, 2025 | tipranks.comSanofi’s Promising Diabetes Study: A Potential Game-Changer for Type 1 Diabetes TreatmentAugust 24, 2025 | tipranks.comSanofi India Launches ‘Saksham Niveshak’ Campaign to Engage ShareholdersAugust 23, 2025 | msn.comSanofi’s Dupilumab Study: A Potential Game-Changer for Chronic Pruritus TreatmentAugust 22, 2025 | tipranks.comSanofi’s New Vaccine Trial: A Potential Game-Changer for Infant HealthAugust 22, 2025 | tipranks.comRegeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis TreatmentAugust 22, 2025 | tipranks.comSanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer in Pediatric HealthAugust 22, 2025 | tipranks.comSanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer?August 22, 2025 | tipranks.comRegeneron and Sanofi’s Itepekimab Study: A Potential Game-Changer for COPD TreatmentAugust 21, 2025 | tipranks.comSanofi’s Phase 3 Study on Riliprubart for CIDP: A Potential Game-ChangerAugust 20, 2025 | tipranks.comSanofi’s SAR445877 Study: A Potential Breakthrough in Cancer TreatmentAugust 19, 2025 | tipranks.comSanofi’s Phase 3 Study on Riliprubart: A Potential Game-Changer for CIDP TreatmentAugust 19, 2025 | tipranks.comNovavax Strengthens Position with Vaccine Approval and Sanofi PartnershipAugust 18, 2025 | msn.comThe Three Categories Of AI Driving a Pharma RevolutionAugust 14, 2025 | forbes.comSanofi’s New Clinical Study: A Potential Game-Changer in Nephrology?August 13, 2025 | msn.comSanofi’s Phase 3 Study on Frexalimab: A Potential Game-Changer in MS TreatmentAugust 13, 2025 | msn.comSanofi reportedly halts sales of cholesterol drug Praluent in China amid limited availabilityAugust 12, 2025 | msn.comSanofi stops supply of high cholesterol drug to China due to limited availabilityAugust 12, 2025 | reuters.comJP Morgan Upgrades Sanofi - Depositary Receipt () (SNY)August 8, 2025 | msn.comSanofi’s New Phase 3 Study: A Potential Game-Changer in Type 1 Diabetes TreatmentAugust 8, 2025 | msn.comUS appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companiesAugust 7, 2025 | reuters.comNovavax CFO Says Sanofi To Cover Majority Of Future Nuvaxovid Study Costs, Retail Urges Partnership DiversificationAugust 7, 2025 | msn.comO'Reilly lawsuit alleges prescription managers, manufacturers inflate insulin costsAugust 7, 2025 | msn.comWhat's Driving the Market Sentiment Around Sanofi?August 5, 2025 | benzinga.comSanofi Consumer Healthcare spurts after Q2 resultsAugust 5, 2025 | msn.comRegeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping.August 1, 2025 | msn.comSanofi raises annual sales growth expectations on strong Dupixent demandJuly 31, 2025 | msn.comSanofi Upbeat on Sales Outlook After Faster-Than-Expected GrowthJuly 31, 2025 | msn.comNew model predicts mRNA protein production, accelerating drug and vaccine discoveryJuly 26, 2025 | msn.comKling Bio and Sanofi link for antibodies and epitopes discoveryJuly 25, 2025 | msn.comNew AI tool accelerates mRNA-based treatments for viruses, cancers, genetic disordersJuly 25, 2025 | msn.comSanofi concludes Blueprint Medicines acquisitionJuly 21, 2025 | finance.yahoo.comSanofi: Sanofi completes acquisition of Blueprint MedicinesJuly 18, 2025 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Sarepta Therapeutics (SRPT)July 18, 2025 | theglobeandmail.comThermo Fisher acquires Sanofi’s steriles manufacturing site in USJuly 17, 2025 | finance.yahoo.comEmcure, Sanofi tie up for anti-diabetic rangeJuly 17, 2025 | msn.comEmcure, Sanofi ink distribution pact for oral anti-diabetic products in IndiaJuly 16, 2025 | msn.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.401.11▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼76▲SAN Articles Average Week Get the Latest News and Ratings for SAN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sanofi and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Merck KGaA News Today Fresenius Medical Care News Today Sartorius Aktiengesellschaft News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAN Stock Alerts